"Biomarkers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc.
Descriptor ID |
D015415
|
MeSH Number(s) |
D23.101
|
Concept/Terms |
Biomarkers- Biomarkers
- Markers, Biological
- Biologic Markers
- Markers, Biologic
- Biologic Marker
- Marker, Biologic
- Marker, Biological
- Biological Marker
- Biological Markers
Serum Markers- Serum Markers
- Markers, Serum
- Marker, Serum
- Serum Marker
Surrogate Endpoints- Surrogate Endpoints
- Endpoints, Surrogate
- Surrogate End Points
- End Points, Surrogate
- Surrogate End Point
- End Point, Surrogate
- Surrogate Endpoint
- Endpoint, Surrogate
Viral Markers- Viral Markers
- Markers, Viral
- Viral Marker
- Marker, Viral
Biochemical Marker- Biochemical Marker
- Biochemical Markers
- Markers, Biochemical
- Marker, Biochemical
Markers, Immunologic- Markers, Immunologic
- Immune Markers
- Markers, Immune
- Marker, Immunologic
- Immunologic Markers
- Immune Marker
- Marker, Immune
- Immunologic Marker
Surrogate Markers- Surrogate Markers
- Markers, Surrogate
- Marker, Surrogate
- Surrogate Marker
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers".
This graph shows the total number of publications written about "Biomarkers" by people in this website by year, and whether "Biomarkers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 3 | 3 |
1995 | 0 | 6 | 6 |
1996 | 0 | 9 | 9 |
1997 | 1 | 5 | 6 |
1998 | 0 | 6 | 6 |
1999 | 0 | 7 | 7 |
2000 | 1 | 11 | 12 |
2001 | 3 | 13 | 16 |
2002 | 0 | 11 | 11 |
2003 | 3 | 15 | 18 |
2004 | 2 | 12 | 14 |
2005 | 2 | 18 | 20 |
2006 | 0 | 19 | 19 |
2007 | 1 | 28 | 29 |
2008 | 4 | 37 | 41 |
2009 | 6 | 30 | 36 |
2010 | 8 | 35 | 43 |
2011 | 13 | 51 | 64 |
2012 | 10 | 55 | 65 |
2013 | 16 | 65 | 81 |
2014 | 8 | 62 | 70 |
2015 | 7 | 72 | 79 |
2016 | 13 | 68 | 81 |
2017 | 9 | 76 | 85 |
2018 | 9 | 83 | 92 |
2019 | 13 | 76 | 89 |
2020 | 13 | 69 | 82 |
2021 | 14 | 77 | 91 |
2022 | 0 | 42 | 42 |
2023 | 1 | 46 | 47 |
2024 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers" by people in Profiles.
-
Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis. Allergy Asthma Proc. 2024 Mar 01; 45(2):97-99.
-
Circulating microRNA Biomarkers of Thiazide Response in Hypertension. J Am Heart Assoc. 2024 Feb 20; 13(4):e032433.
-
Metabolic signatures of thymomas: potential biomarkers and treatment targets. Eur J Cardiothorac Surg. 2024 Feb 01; 65(2).
-
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis. Lancet Neurol. 2024 Feb; 23(2):168-177.
-
Editors' Note: Association of Polysomnographic Sleep Parameters With Neuroimaging Biomarkers of Cerebrovascular Disease in Older Adults With Sleep Apnea. Neurology. 2024 Feb 27; 102(4):e208124.
-
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling. Stroke. 2024 01; 55(1):31-39.
-
Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma. Cells. 2023 12 13; 12(24).
-
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition. J Clin Oncol. 2024 Feb 01; 42(4):467-480.
-
Prospective observational study to validate a next-generation sequencing blood RNA signature to predict early kidney transplant rejection. Am J Transplant. 2024 Mar; 24(3):436-447.
-
Low daily oral PrEP adherence and low validity of self-report in a randomized trial among PWID in Ukraine. Int J Drug Policy. 2024 Jan; 123:104284.